Following the struggle for control: Novolog appoints a new CEO

The logistics and healthcare services company Novolog has announced the appointment of Zeev Mansour as CEO, replacing Aviad Busi, who departed amid a dramatic struggle for control and a subsequent board overhaul.

Approximately two weeks ago, the Pozis family, Novolog's founders, increased their stake in the company from 27% to 44% at a price significantly above market value. This move was designed to prevent an investment that would have diluted their holdings and challenged their status as the company's primary shareholders.

Oded Pozis, a third-generation family member who took over the family's involvement in Novolog from his father, Udi Pozis, in May, led the consolidation effort. Following the share purchase, he appointed himself chairman of the board and replaced all directors except for the independent ones. By the end of last week, both the CEO and CFO had resigned.

Mansour brings significant logistics expertise to the role. He previously served as CEO of LogistiCare (part of the Maman Group), where he oversaw 15 logistics centers. Novolog noted that during his tenure, Mansour led a turnaround that moved the company from losses to profitability while expanding operations and implementing advanced automation. Previously, he managed the supply chain division at Shufersal, where he established a major logistics center, and held roles at Honigman, General Mills, and Tnuva.

The new CEO's primary challenge

Mansour's appointment signals a strategic shift under the new ownership. While logistics generates the bulk of Novolog's revenue, profit margins remain relatively thin. The company has also struggled to fully recover from operational disruptions following an ERP system implementation in late 2024.

Under Oded Pozis, the company intends to focus on efficiency and improving the profitability of its logistics division. The company faces a classic dilemma for a public entity: balancing the market's demand for stability with the need for growth. Between 2020 and 2021, under CEO Eran Taus, the company aggressively acquired healthcare service assets, but successor Aviad Busi later sold off many of these to refocus on core logistics. Due to the ERP crisis and recent corporate turmoil, Busi was unable to fully execute his strategy. Mansour must now determine how to manage non-logistics segments and whether to pursue further healthcare expansion.

Commenting on the appointment, Oded Pozis stated:

"Zeev brings a combination of significant managerial and business experience with deep expertise in Novolog's areas of activity. I am convinced that his capabilities will assist us in realizing Novolog's potential, improving profitability, and leading the company to its next stage of growth."

Last week, Novolog released its second-quarter 2026 results. Revenues for the first six months rose by approximately 1% to 957 million NIS, while operating profit fell by about 1.5% to 13.7 million NIS. Net profit dropped significantly from 5.8 million to roughly 1 million NIS, which the company attributed primarily to dollar exchange rates and rising interest expenses.